Skip to content

Drug interactions

Rifabutin + Rimegepant

Severity: Moderate

Rifabutin and Rimegepant: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rifabutin induces CYP3A4 and can reduce rimegepant exposure, possibly causing loss of migraine efficacy. The induction effect is weaker than that of rifampicin but still relevant.

What this interaction means in plain words

Rifabutin and Rimegepant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Rifabutin belongs to Anti Bacterial; Rimegepant belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

CYP3A4 induction by rifabutin accelerates the metabolism of rimegepant.

What to do

Avoid concurrent use as labeling advises for moderate CYP3A4 inducers; use an alternative acute migraine therapy or monitor efficacy closely.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Rifabutin and Rimegepant, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Rifabutin with Rimegepant?

MediHelp rates the interaction as moderate. Rifabutin and Rimegepant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Rifabutin induces CYP3A4 and can reduce rimegepant exposure, possibly causing loss of migraine efficacy. The induction effect is weaker than that of rifampicin but still relevant.

How serious is the interaction between Rifabutin and Rimegepant?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use as labeling advises for moderate CYP3A4 inducers; use an alternative acute migraine therapy or monitor efficacy closely.

What other medicines interact with Rimegepant?

MediHelp also lists interactions of Rimegepant with, for example, Amobarbital, Atazanavir, Butabarbital. The full list is on the Rimegepant page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in